Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of UTRN mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of UTRN mRNA | affects expression | 16483693
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UTRN mRNA | affects cotreatment|increases expression | 18164116
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of UTRN mRNA | decreases expression | 20064835 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of UTRN mRNA | decreases expression | 20382639 19150397
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of UTRN mRNA | increases expression | 20106945
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of UTRN mRNA | increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UTRN mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UTRN mRNA | affects cotreatment|increases expression | 18164116
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of UTRN mRNA | decreases expression | 18548127
|
D008942 |
Mitoxantrone |
UTRN protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of UTRN mRNA | decreases expression | 20106945
|
C016837 |
zinc chloride |
zinc chloride binds to UTRN protein | affects binding | 17009962
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.01 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.66 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
11.66 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.66 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.71 | 17620307 18056438 16434500 19052882 19061943 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.71 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.06 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.25 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.18 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.80 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.80 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.80 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.91 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
2.91 | 18210153 16807293 16288022 18056438 11831363 19335982 20935162 19418558 17173139 18785209 20524982 10672840 17978847 20007298 18393292 20432363 19539802 16569478 17428255 21159647 3084413 17162532 19701751 3581430 19052882 18978308 17761372 19394651 18506893 17055752 17138121 18691550 19171122 20101231 19822196 19208518 10737359 16328049 19383236 20084675 19519916 16502159 18971187 16698587 18665156 20512989 16878318 19919837 20214788 16935385 19107877 16681979 18788625 20727157 16779866 20514400 16830150 18494052 16540662 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.08 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 18670907 16120746 18850075 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.66 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.71 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.71 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.71 | 2727394 7505956 17174075 21159647 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.74 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.74 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.02 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 12621046 16354765 15668235 15340226 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.32 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.32 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.34 | 15968718 11529661 19420014 10915739 2444490 12705907 10774834 10663392 19923254 19416960 19164858 19370779 16485898 16109766 15619225 18071297 12594235 11743745 11421492 14725611 12392966 16781746 16393943 16081117 17522070 16177239 12958197 11461765 19739265 17562736 18713872 14550746 11287661 12540782 16227642 11739529 12153990 19085960 11834606 17906064 14986274 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.34 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.34 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.32 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.51 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.33 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.46 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.46 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.18 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.18 | 21071580 20387270 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.07 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.07 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.89 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.41 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.67 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.67 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.24 | 16019553 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.62 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.07 | 16120746 15340226 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 16354765 8697196 16959395 18606429 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.81 | 16870215 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.10 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.10 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.12 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.12 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.66 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.05 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.05 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.85 | 12371664 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.84 | 18172266 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.89 | 18665156 18522880 18407596 20032147 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.01 | 11587558 16611625 19014921 19460945 12587719 12969438 19784758 16610002 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.01 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.37 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
11.11 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
11.11 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
11.11 | 21278145 10737359 19499222 20101389 19812893 2422723 12771043 20492335 18754104 21071580 20452335 21047994 18644402 21167192 19690152 20118626 19426721 15175105 20137499 19642983 19638242 18977376 12112319 20434301 19256749 16942905 9163691 2862719 19090486 18648771 20405173 19551842 18978307 19850985 20501860 19294768 19833225 15885732 20583210 19255062 19427195 19254457 19996281 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.11 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
10.36 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.36 | 19519916 18253720 19126423 18079962 16267830 18164116 18308698 18775883 3124819 18544905 9362446 21159647 19004024 19009564 2563599 18093689 17854601 17174075 17942915 18282651 19539802 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.36 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.42 | 18520028 18569708 17053015 20869020 6695378 20064080 18816296 20464547 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.42 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.42 | 19555203 11884234 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.74 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.01 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.30 | 16381670 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.61 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.57 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
5.57 | 16640825 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.66 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.41 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.58 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.58 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.33 | 20387270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.50 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.46 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.36 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.36 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11896295 11118676 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.37 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
3.37 | 16205645 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.27 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.67 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.67 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.36 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.36 | 18456281 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.09 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.22 | 17053015 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.12 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.20 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.66 | 17120751 |